Cargando…

Resurgence?

Detalles Bibliográficos
Autor principal:	Mann, Douglas L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editor's Page
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326268/ https://www.ncbi.nlm.nih.gov/pubmed/34368513 http://dx.doi.org/10.1016/j.jacbts.2021.06.005

Ejemplares similares

JACC: Basic to Translational Science 2020 Top Reviewers:: A Year to Remember
por: Mann, Douglas L.
Publicado: (2021)

The Thomas Force Young Investigator Award
por: Mann, Douglas L.
Publicado: (2021)

Will Artificial Intelligence Transform Translational Medicine: (Not So) Elementary, My Dear Watson
por: Mann, Douglas L.
Publicado: (2021)

Now That We Have an Effective Vaccine for COVID-19, Will It Also Inoculate Us Against the Virus of Indifference?
por: Mann, Douglas L.
Publicado: (2021)

Translational Science, Vaccines, and the Milk of Human Kindness
por: Mann, Douglas L.
Publicado: (2021)

Are Academic Medical Centers Placing Translational Scientists on the Endangered Species List?: A Call for Climate Change to Preserve the Species
por: Mann, Douglas L.
Publicado: (2017)

The 2017 March for Science
por: Mann, Douglas L.
Publicado: (2017)

Truth and Truthiness in Translational Research
por: Mann, Douglas L.
Publicado: (2017)

Can President Trump’s (Second) Choice for the Secretary of the Department of Human Health and Services Make Translational Research Great Again?
por: Mann, Douglas L.
Publicado: (2018)

The Rising Cost of Developing Cardiovascular Therapies and Reproducibility in Translational Research: Do Not Blame It (All) on the Bench
por: Mann, Douglas L.
Publicado: (2017)

Fake News, Alternative Facts, and Things That Just Are Not True: Can Science Survive the Post-Truth Era?
por: Mann, Douglas L.
Publicado: (2018)

JACC: Basic to Translational Science: Quo Vadis?
por: Mann, Douglas L.
Publicado: (2016)

Can Mr. Trump Make Translational Research Great Again?: Three Ways in Which a Trump Presidency Can Affect Translational Research
por: Mann, Douglas L.
Publicado: (2017)

Deus Ex Machina: Why Mechanism Matters in Translational Research
por: Mann, Douglas L.
Publicado: (2017)

JACC: Basic to Translational Science: The End of the Beginning
por: Mann, Douglas L.
Publicado: (2019)

What Are the Off-Target Effects of Plan “S” For Translational Investigators?
por: Mann, Douglas L.
Publicado: (2019)

Q4 Vital Signs: Can Machine Learning Protect Patients From the Machinery of Modern Medicine?
por: Mann, Douglas L.
Publicado: (2019)

Scott Gottlieb’s Resignation as FDA Commissioner Is a Loss for Translational Medicine
por: Mann, Douglas L.
Publicado: (2019)

Why Do Medical Journals Exist in the 21st Century?: Some Thoughts on the Next 5 Years of JACC: Basic to Translational Science
por: Mann, Douglas L.
Publicado: (2020)

Warped Speed: How COVID-19 Transfected and Transformed Medical Journals
por: Mann, Douglas L.
Publicado: (2020)

SARS-CoV-2 and Bats: From Flight to Fighting COVID-19
por: Mann, Douglas L.
Publicado: (2020)

JACC: Basic to Translational Science and Preprint Servers: Accelerating the Pace of Translation
por: Mann, Douglas L.
Publicado: (2020)

Can One Person Make a Difference?: Remembering the Remarkable Life and Career of Alfred Bove
por: Mann, Douglas L.
Publicado: (2019)

Chinese Health Care Workers and COVID-19: For Whom the Bell Tolls
por: Mann, Douglas L.
Publicado: (2020)

What I Learned From the Impeachment Process: Confessions of a Translationalist
por: Mann, Douglas L.
Publicado: (2020)

Will COVID-19 Transform Translational Medicine?
por: Mann, Douglas L.
Publicado: (2020)

Fake It Till You Make It: What Every Translational Investigator Can Learn From the Rise and Fall of Theranos
por: Mann, Douglas L.
Publicado: (2022)

The Sad Bells of Ukraine: Is There Hope for the Future?
por: Mann, Douglas L.
Publicado: (2022)

When Pigs Fly What Will the Future of Heart Failure Therapeutics Look Like?
por: Mann, Douglas L.
Publicado: (2022)

The Law of Holes: Why Do Translational Scientists Keep Digging?
por: Mann, Douglas L.
Publicado: (2022)

Will Gene Editing Orphanize Rare Diseases?
por: Mann, Douglas L.
Publicado: (2023)

Synthetic Biology, Directed Evolution, and the Rational Design of New Cardiovascular Therapeutics: Are We There Yet?
por: Mann, Douglas L.
Publicado: (2023)

JACC: Basic to Translational Science: The Apple That Falls Closely to the JACC Family Tree
por: Fuster, Valentin, et al.
Publicado: (2018)

The Tafamidis Drug Development Program: A Translational Triumph
por: Maurer, Mathew S., et al.
Publicado: (2018)

Remembering Dr. James T. Willerson
por: Mann, Douglas L., et al.
Publicado: (2020)

Will the Precision Medicine Initiative Transform Cardiovascular Translational Research?
por: Mann, Douglas L., et al.
Publicado: (2016)

In the Ongoing Conflict Between Ideology and Immunity, Which Side Will Protect the Children From Post-Acute Sequelae of COVID-19?
por: Verma, Amanda K., et al.
Publicado: (2021)

Training the Next Generation of Translational Cardiovascular Investigators: Is the Pipeline Half Full or Half Empty?
por: Nerbonne, Jeanne M., et al.
Publicado: (2016)

Potential Effect of Brexit on Cardiovascular Translational Science
por: Shah, Ajay M., et al.
Publicado: (2016)

The Affordable Care Act’s Hospital Readmissions Reduction Program: Has the Biology Had Time to Catch Up With the Regulation?
por: Mann, Douglas L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kjaa1u41aguvddqikp9p3p9ufq